D. George

596 total citations
36 papers, 463 citations indexed

About

D. George is a scholar working on Hematology, Public Health, Environmental and Occupational Health and Oncology. According to data from OpenAlex, D. George has authored 36 papers receiving a total of 463 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Hematology, 11 papers in Public Health, Environmental and Occupational Health and 8 papers in Oncology. Recurrent topics in D. George's work include Hematopoietic Stem Cell Transplantation (17 papers), Acute Lymphoblastic Leukemia research (11 papers) and Renal Transplantation Outcomes and Treatments (6 papers). D. George is often cited by papers focused on Hematopoietic Stem Cell Transplantation (17 papers), Acute Lymphoblastic Leukemia research (11 papers) and Renal Transplantation Outcomes and Treatments (6 papers). D. George collaborates with scholars based in United States, Poland and Australia. D. George's co-authors include Mitchell S. Cairo, James H. Garvin, Prakash Satwani, Monica Bhatia, G. Del Toro, M.B. Bradley, Carmella van de Ven, Joseph E. Schwartz, Lauren Harrison and R. Hawks and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Annals of Oncology.

In The Last Decade

D. George

35 papers receiving 458 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
D. George United States	10	238	128	113	78	64	36	463
Consuelo Mancías‐Guerra Mexico	11	183 0.8×	170 1.3×	60 0.5×	48 0.6×	46 0.7×	31	436
Maria Vittoria Gazzola Italy	9	175 0.7×	82 0.6×	60 0.5×	33 0.4×	55 0.9×	13	332
Beate Winkler Germany	14	142 0.6×	109 0.9×	54 0.5×	142 1.8×	165 2.6×	36	524
Daria Sollazzo Italy	13	178 0.7×	109 0.9×	24 0.2×	17 0.2×	64 1.0×	25	407
Hayoung Choi South Korea	13	108 0.5×	187 1.5×	61 0.5×	38 0.5×	31 0.5×	22	517
S Mancini Italy	10	52 0.2×	143 1.1×	21 0.2×	96 1.2×	102 1.6×	17	465
Alexandra Russo Germany	12	42 0.2×	60 0.5×	102 0.9×	194 2.5×	58 0.9×	28	490
Chooi Fun Leong Malaysia	11	110 0.5×	123 1.0×	11 0.1×	47 0.6×	21 0.3×	41	311
K. Weigel Germany	9	48 0.2×	171 1.3×	22 0.2×	46 0.6×	14 0.2×	22	552
Francesca Argiolu Italy	7	218 0.9×	313 2.4×	135 1.2×	18 0.2×	21 0.3×	9	447

Countries citing papers authored by D. George

Since Specialization

Citations

This map shows the geographic impact of D. George's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by D. George with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites D. George more than expected).

Fields of papers citing papers by D. George

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by D. George. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by D. George. The network helps show where D. George may publish in the future.

Co-authorship network of co-authors of D. George

This figure shows the co-authorship network connecting the top 25 collaborators of D. George. A scholar is included among the top collaborators of D. George based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with D. George. D. George is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Lim, Emerson A., James A. Reeves, David R. Spigel, et al.. (2022). 1396P Phase II study of AZD4635 in combination with durvalumab or oleclumab in patients (pts) with metastatic castrate-resistant prostate cancer (mCRPC). Annals of Oncology. 33. S1182–S1183. 3 indexed citations

Bhatia, Monica, Zhezhen Jin, Claire E. Baker, et al.. (2014). Reduced toxicity, myeloablative conditioning with BU, fludarabine, alemtuzumab and SCT from sibling donors in children with sickle cell disease. Bone Marrow Transplantation. 49(7). 913–920. 75 indexed citations

Satwani, Prakash, Zhezhen Jin, Paul L. Martin, et al.. (2014). Sequential myeloablative autologous stem cell transplantation and reduced intensity allogeneic hematopoietic cell transplantation is safe and feasible in children, adolescents and young adults with poor-risk refractory or recurrent Hodgkin and non-Hodgkin lymphoma. Leukemia. 29(2). 448–455. 30 indexed citations

Felix, Sarah, et al.. (2012). Removable silicon insertion stiffeners for neural probes using polyethylene glycol as a biodissolvable adhesive. PubMed. 2012. 871–874. 49 indexed citations

Milone, Michael C., Ian M. Waxman, Yi‐Ju Li, et al.. (2012). The pharmacokinetics and safety of twice daily i.v. BU during conditioning in pediatric allo-SCT recipients. Bone Marrow Transplantation. 48(1). 19–25. 6 indexed citations

Milone, Michael C., Ian M. Waxman, Leslie M. Shaw, et al.. (2011). Iv Busulfan Administered Q12 Vs Q6 Hrs During Conditioning of Pediatric Allogeneic Stem Cell Transplant (AlloSCT) Recipients Has Comparable Pharmacokinetics and Significant Reduction in Nursing/Pharmacist Costs. Biology of Blood and Marrow Transplantation. 17(2). S258–S258. 1 indexed citations

Jin, Zhezhen, Charles S. Kleinman, Monica Bhatia, et al.. (2010). Pericardial effusion post-SCT in pediatric recipients with signs and/or symptoms of cardiac disease. Bone Marrow Transplantation. 46(4). 529–538. 25 indexed citations

Styczyński, Jan, Ian M. Waxman, Carmella van de Ven, et al.. (2010). A pilot study of reduced toxicity conditioning with BU, fludarabine and alemtuzumab before the allogeneic hematopoietic SCT in children and adolescents. Bone Marrow Transplantation. 46(6). 790–799. 29 indexed citations

Militano, Olga, Monica Bhatia, Zhezhen Jin, et al.. (2009). Pharmacokinetics (PK) Of IV And Po Mycophenolate Mofetil (MMF) In Age Adjusted Pediatric And Adolescent Allogeneic Stem Cell Transplant (AlloSCT) Recipients: Significantly Higher CLss AND Vss IN PATIENTS <6 YEARS OF AGE. Biology of Blood and Marrow Transplantation. 15(2). 132–133.

10.

Bradley, M.B., Prakash Satwani, Erin Morris, et al.. (2007). Reduced intensity allogeneic umbilical cord blood transplantation in children and adolescent recipients with malignant and non-malignant diseases. Bone Marrow Transplantation. 40(7). 621–631. 60 indexed citations

11.

Roman, Eve, Erin Cooney, Olga Militano, et al.. (2007). 76: Reduced intenity allogeneic stem cell transplantion followed by targeted consolidation immunotherapy with gemtuzumab ozogamicin in children and adolescents with CD33+ acute myeloid leukemia. Biology of Blood and Marrow Transplantation. 13(2). 30–31. 2 indexed citations

12.

Militano, Olga, Leslie M. Shaw, Michal Figurski, et al.. (2007). 315: Pharmacokinetics (PK) of mycophenolate mofetil (MMF) in pediatric allogeneic stem cell transplant (AlloSCT) recipients. Biology of Blood and Marrow Transplantation. 13(2). 114–115. 1 indexed citations

13.

Militano, Olga, G. Del Toro, Prakash Satwani, et al.. (2006). Sequential administration of sargramostim (GM-CSF) and filgrastim (G-CSF) in pediatric allogeneic stem cell transplant (allosct) recipients undergoing myeloablative (MA) conditioning: Cost-effective and more rapid platelet recovery in UCB recipients. Biology of Blood and Marrow Transplantation. 12(2). 43–43. 2 indexed citations

14.

Prince, H. Miles, D. George, Ricky W. Johnstone, et al.. (2006). LBH589, a novel histone deacetylase inhibitor (HDACi), treatment of patients with cutaneous T-cell lymphoma (CTCL). Changes in skin gene expression profiles related to clinical response following therapy. Journal of Clinical Oncology. 24(18_suppl). 7501–7501. 6 indexed citations

15.

Solari, Sandra, et al.. (2005). Rifampicin Can Alter Pharmacokinetics Of Busulfan in Patients Given Bone Marrow Transplantation. Therapeutic Drug Monitoring. 27(2). 254–254. 1 indexed citations

16.

Styczyński, Jan, James H. Garvin, David G. Savage, et al.. (2004). Outcomes of unrelated cord blood transplantation in pediatric recipients. Bone Marrow Transplantation. 34(2). 129–136. 35 indexed citations

17.

Avigan, David, D. George, Philip W. Kantoff, et al.. (2004). Interim safety and efficacy results from a phase I/II study of vaccination with electrofused allogeneic dendritic cells/autologous tumor-derived cells in patients with stage IV renal cell carcinoma. Journal of Clinical Oncology. 22(14_suppl). 2526–2526. 3 indexed citations

18.

Toro, G. Del, Prakash Satwani, Lauren Harrison, et al.. (2004). A pilot study of reduced intensity conditioning and allogeneic stem cell transplantation from unrelated cord blood and matched family donors in children and adolescent recipients. Bone Marrow Transplantation. 33(6). 613–622. 56 indexed citations

19.

Toro, G. Del, Prakash Satwani, M.B. Bradley, et al.. (2004). Reduced intensity conditioning and allogeneic stem cell transplantation (RI AlloSCT) in children and adolescents with malignancies following unrelated cord blood and matched family donor AlloSCT results in ≥90% achieving ≥98% donor chimerism. Journal of Clinical Oncology. 22(14_suppl). 8506–8506. 1 indexed citations

20.

Baltzan, Marc, et al.. (1997). Fate of recurrent acute interstitial cellular rejection in an HLA identical kidney transplant recipient: impact of donor microchimerism.. PubMed. 48(5). 300–6. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact